Science Explorer Back to mapMap
Discussion
Topic · Oncology

COVID-19 and healthcare impacts

COVID-19 and healthcare impacts is a research topic within Oncology. Science Explorer counts 29k research works in it since 1951. 9.9% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the impact of the COVID-19 pandemic on cancer patients, healthcare systems, and clinical outcomes. It covers topics such as mortality, surgery, delayed diagnosis and treatment, emergency department visits, and the management of cancer care during the pandemic.

  • Cancer
  • COVID-19
  • Pandemic
  • Mortality
  • Surgery
  • Healthcare
  • Emergency Department Visits
  • Oncology
  • Clinical Trials
  • Stroke
Research works
29k
fractional, since 1951
In the world top 10%
2.9k
per year above
Top-10% rate
9.9%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-16%
the tick is no change
Largest producer
United States
42% of the 10 largest, 2022-now

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead COVID-19 and healthcare impacts research?

By volume, the United States and the United Kingdom publish the most (3.4k and 1k works in 2022-now).

By volume, 2022-now

  1. 1 United States 3.4k works
  2. 2 United Kingdom 1k works
  3. 3 India 557 works
  4. 4 Italy 511 works
  5. 5 China 508 works
  6. 6 Brazil 500 works
  7. 7 Türkiye 472 works
  8. 8 Canada 430 works
  9. 9 Spain 364 works
  10. 10 Germany 331 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 42.2%United Kingdom: 12.5%India: 6.9%Italy: 6.3%6 others listed: 32.2%42%largest
United States3,416 · 42.2%United Kingdom1,014 · 12.5%India557 · 6.9%Italy511 · 6.3%6 others listed2,605 · 32.2%

Shares of the rows listed above, not of the whole node.

Which institutions lead COVID-19 and healthcare impacts research?

By volume in 2022-now, Harvard University publishes the most COVID-19 and healthcare impacts research, followed by University of North Carolina at Chapel Hill and University of Toronto.

Who are the leading researchers in COVID-19 and healthcare impacts?

The most-cited researchers publishing on COVID-19 and healthcare impacts include David Moher, Ahmedin Jemal and Christopher J L Murray.

  1. 1 David Moher Canada 898k citations
  2. 2 Ahmedin Jemal United States 761k citations
  3. 3 Christopher J L Murray United States 583k citations
  4. 4 Rebecca L. Siegel United States 582k citations
  5. 5 Freddie Bray France 550k citations
  6. 6 Jacques Ferlay France 486k citations
  7. 7 Rob Knight United States 468k citations
  8. 8 Simon Iain Hay United States 452k citations
  9. 9 Theo Vos United States 439k citations
  10. 10 George Davey Smith United Kingdom 435k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in COVID-19 and healthcare impacts?

The most cited paper in COVID-19 and healthcare impacts is "Clinical Characteristics of Coronavirus Disease 2019 in China" (Wei‐jie Guan et al., 2020), with 31,256 citations. Next come "Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study" (29,236) and "Cancer statistics, 2023" (17,031).

Most cited papers
#PaperReleasedCitations
1 Clinical Characteristics of Coronavirus Disease 2019 in China Wei‐jie Guan et al. · New England Journal of Medicine Open access 28 Feb 2020 31,256
2 Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study Fei Zhou, Ting Yu, Ronghui Du et al. · The Lancet Open access Mar 2020 29,236
3 Cancer statistics, 2023 Rebecca L. Siegel, Kimberly D. Miller, Nikita Sandeep Wagle et al. · CA A Cancer Journal for Clinicians Open access 2023 17,031
4 Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram et al. · International Journal of Cancer Open access 23 Oct 2018 7,833
5 Factors associated with COVID-19-related death using OpenSAFELY Elizabeth Williamson et al. · Nature Open access 8 Jul 2020 6,783
All 99 most cited papers, with filters and sorting

Where is COVID-19 and healthcare impacts research done?

The largest centres of COVID-19 and healthcare impacts research in 2022-now are London (United Kingdom), New York (United States), Boston (United States) and Istanbul (Türkiye). Among places with at least 20 works in it, it is an unusually large share of all research in The Bronx and Timișoara.

Largest cities, 2022-now

  1. 1 LondonUnited Kingdom 291 works
  2. 2 New YorkUnited States 181 works
  3. 3 BostonUnited States 140 works
  4. 4 IstanbulTürkiye 140 works
  5. 5 TorontoCanada 133 works
  6. 6 São PauloBrazil 115 works
  7. 7 TehranIran 111 works
  8. 8 Chapel HillUnited States 106 works
  9. 9 RomeItaly 102 works
  10. 10 MadridSpain 97 works

Where it is the local speciality

  1. The BronxUS · 23.7 works5.8×
  2. TimișoaraRO · 21.6 works5.5×
← less than its size predicts1×more →

Location quotient: how much more of its research is in COVID-19 and healthcare impacts than the world average.

See COVID-19 and healthcare impacts on the map

Where is the best place to study COVID-19 and healthcare impacts?

Among universities, judged by research, Harvard University, University of Toronto and London School of Hygiene & Tropical Medicine score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%20%40%mean 18.95%fractional works in this field (log) →share of work in the world top 10% →London School of Hyg…Harvard UniversityKarolinska InstitutetUniversity of Toronto
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Citation excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1Harvard UniversityUnited States 65.218.4%3.9×135 -37.4%
2University of TorontoCanada 64.816.9%4.0×89 +4.8%
3London School of Hygiene & Tropical MedicineUnited Kingdom 63.228.7%7.0×12 -24.9%
4Karolinska InstitutetSweden 60.917.3%4.7×29 +32.6%
5Victor Babeș University of Medicine and Pharmacy TimișoaraRomania 60.524.6%16.6×16 +777.4%
6Boston UniversityUnited States 56.025.2%3.2×17 +5.3%
7University of North Carolina at Chapel HillUnited States 53.22.9%5.8×112 +195.6%
8University of OxfordUnited Kingdom 52.920.9%2.1×32 -26.9%
9Stanford UniversityUnited States 51.218.7%2.4×39 -22.9%
10University College LondonUnited Kingdom 50.815.9%2.6×45 -43.4%

Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in COVID-19 and healthcare impacts, country by country

Is COVID-19 and healthcare impacts research growing?

Output in 2022-2025 was 16% lower than in 2018-2021, peaking in 2021.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is COVID-19 and healthcare impacts as a percentage of every work published that year, 0.039% in 2024.

still counting0.050%0.10%0.15%COVID-19 and healthcare impacts0.025% in 202519801990200020102020

Fractional works of COVID-19 and healthcare impacts over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%COVID-19 and healthcare impacts10.3% in 20252020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about COVID-19 and healthcare impacts. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.